Page 90 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 90
CHAPTER 4
32. AletahaD,NeogiT,SilmanAJ,FunovitsJ,FelsonDT,BinghamCO,III,etal.2010Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
33. KoopmanC,VaartjesI,BlokstraA,VerschurenWM,VisserM,DeegDJ,etal.Trendsinrisk factors for coronary heart disease in the Netherlands. BMC Public Health 2016;16:835.
34. Unriza-Puin S, Bautista-Molano W, Lafaurie GI, Valle-Onate R, Chalem P, Chila-Moreno L, et al. Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives? Clin Rheumatol 2017;36:799-806.
35. Hall J, Grant J, Blake D, Taylor G, Garbutt G. Cardiorespiratory responses to aquatic treadmill walking in patients with rheumatoid arthritis. Physiother Res Int 2004;9:59-73.
36. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and
interventions. Rheumatology (Oxford) 2004;43:1219-23.
37. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha
inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 1994;91:4854-8.
38. ArshadA,RashidR,BenjaminK.Theeffectofdiseaseactivityonfat-freemassandresting energy expenditure in patients with rheumatoid arthritis versus noninflammatory
arthropathies/soft tissue rheumatism. Mod Rheumatol 2007;17:470-5.
39. Resmini E, Farkas C, Murillo B, Barahona MJ, Santos A, Martinez-Momblan MA, et al. Body composition after endogenous (Cushing’s syndrome) and exogenous (rheumatoid
arthritis) exposure to glucocorticoids. Horm Metab Res 2010;42:613-8.
40. KonijnNP,vanTuylLH,BoersM,vandeVenPM,denUD,TerWeeMM,etal.Theshort- term effects of two high-dose, step-down prednisolone regimens on body composition
in early rheumatoid arthritis. Rheumatology (Oxford) 2016;55:1615-22.
41. Niederauer CM, Binkley TL, Specker BL. Effect of truncal adiposity on plasma lipid and
lipoprotein concentrations. J Nutr Health Aging 2006;10:154-60.
42. Peppa M, Koliaki C, Hadjidakis DI, Garoflos E, Papaefstathiou A, Katsilambros N, et al.
Regional fat distribution and cardiometabolic risk in healthy postmenopausal women.
Eur J Intern Med 2013;24:824-31.
43. Sardinha LB, Teixeira PJ, Guedes DP, Going SB, Lohman TG. Subcutaneous central fat is
associated with cardiovascular risk factors in men independently of total fatness and
fitness. Metabolism 2000;49:1379-85.
44. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, et al.
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study. Arthritis Res Ther 2006;8:R82.
45. Navarro-Millan I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL, Jr., Chen L, et al. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum 2013;65:1430-8.
46. TuneJD,GoodwillAG,SassoonDJ,MatherKJ.Cardiovascularconsequencesofmetabolic syndrome. Transl Res 2017.
88
